Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Diabetic Macular Edema · Hypercholesterolemia · REGN

Regeneron UK

Regeneron UK Limited

Regeneron UK clinical programs — 126 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Tarrytown, USA HQ
16,715 Employees
Public company Type
REGN · NYSE Ticker
Company details
Status
Public
HQ
Tarrytown, USA
Employees
16,715
Programs
493
Drugs
98
Patents
837
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Regeneron UK projects

126 ClinicalTrials.gov programs sponsored by Regeneron UK.

Regeneron UK has 126 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

126 programs

Clinical programs

Page 3 of 3

  1. REGN727

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  2. REGN727(SAR236553)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 1 small molecule completed

    1 trial

  3. REGN728

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  4. REGN7508 (IV)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  5. REGN7544

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. REGN7999

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  7. REGN846

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  8. REGN88

    Regeneron UK Limited

    Rheumatoid Arthritis

    phase 1 mab completed

    3 trials

  9. REGN9035

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. REGN9533

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  11. REGN9933

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. Rilonacept

    Regeneron UK Limited

    Autoimmune Neurosensory Hearing Loss (ANSHL)

    phase 1 small molecule active

    1 trial

  13. SAR231893 (REGN668)

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  14. SAR231893 (REGN668) DP1

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  15. SC-DARIC33

    Regeneron UK Limited

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  16. Subconjunctival aflibercept

    Regeneron UK Limited

    Corneal Neovascularization

    phase 1 small molecule terminated

    1 trial

  17. VEGF Trap

    Regeneron UK Limited

    Neovascular Age Related Macular Degeneration

    phase 1 small molecule completed

    1 trial

  18. VEGF Trap

    Regeneron UK Limited

    Macular Degeneration

    phase 1 small molecule completed

    1 trial

  19. VEGF Trap-Eye

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 1 small molecule completed

    1 trial

  20. Vonsetamig

    Regeneron UK Limited

    Lupus Nephritis (LN)

    phase 1 small molecule active

    1 trial

  21. aflibercept

    Regeneron UK Limited

    Lymphoma, Non-Hodgkin

    phase 1 small molecule completed

    1 trial

  22. aflibercept (AVE0005)

    Regeneron UK Limited

    Cancer

    phase 1 small molecule completed

    1 trial

  23. aflibercept (AVE0005)

    Regeneron UK Limited

    Neoplasms

    phase 1 small molecule completed

    2 trials

  24. bbT369

    Regeneron UK Limited

    Diffuse Large B Cell Lymphoma (DLBCL)

    phase 1 mab terminated

    1 trial

  25. cemiplimab

    Regeneron UK Limited

    Relapsed/Refractory Aggressive B-Cell Lymphoma

    phase 1 small molecule active

    1 trial

  26. linvoseltamab

    Regeneron UK Limited

    Food Allergy

    phase 1 small molecule active

    1 trial

  27. nesvacumab (REGN910/ SAR307746)

    Regeneron UK Limited

    Solid Tumors

    phase 1 small molecule completed

    2 trials

  28. rilonacept (IL-1 Trap)

    Regeneron UK Limited

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule completed

    1 trial

  29. ziv-aflibercept

    Regeneron UK Limited

    Lymphoma

    phase 1 mab completed

    2 trials

  30. ziv-aflibercept

    Regeneron UK Limited

    Cancer

    phase 1 mab completed

    2 trials

Frequently asked questions

How many clinical projects does Regeneron UK have?

126 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.